Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles BlackRock Says Hedge Funds Are Key as Diversification Falters in Volatile Markets Julie Segal How Short Sellers Are Surviving a Crazy Bull Market — While Waiting for It to End Michelle Celarier Navigating the Multifamily Market Cycle: WDIP’s Strategic Approach to Emerging Opportunities Sponsored by Walker & Dunlop Investment Partners, Inc. (WDIP)